Skip to main content

Table 1 Demographics and baseline characteristics of moderately, severely and critically ill COVID-19 patients

From: An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients

 

Moderately ill Patients

Severely ill patients

Critically ill patients

Total

(n = 11)

(n = 7)

(n = 6)

Age (mean), years

80

85.14

73.33

79.83

Sex (%)

 Male

3 (12.5%)

0

3 (12.5%)

6 (25%)

 Female

8 (33.33%)

7 (29.16%)

3 (12.5%)

18 (75%)

Most frequent comorbidities (%)

 Hypertension

8 (33.33%)

3 (12.5%)

3 (12.5%)

14 (58.33%)

 Diabetes mellitus

4 (16.66%)

1 (4.16%)

3 (12.5%)

8 (33.33%)

 Cardiovascular diseases

2 (8.33%)

2 (8.33%)

3 (12.5%)

7 (29.16%)

 COPD

1 (4.16%)

1 (4.16%)

0

2 (8.33%)

 Cancer

0

1 (4.16%) NSCLC

0

1 (4.16%)

  1. Abbreviations: COPD Chronic obstructive pulmonary disease; NSCLC Non-small cell lung cancer